Effective surgical treatment for obstructive sleep apnea hypopneas syndrome (OSAHS) must be designed to eliminate collapsible soft tissue in the upper airway without interfering with normal function. Creation of a non-collapsible airspace and reduction of airway resistance enables maintaining adequate airflow with normal inspiration efforts. This means that elimination or reduction of apnea hypopneia episodes during sleep, symptom control and further minimizes ongoing damage to multiple systems in difficult strings. Obstructive sleep apnea hypopnea syndrome is often caused by multiple levels of obstruction and therefore requires multi-level treatment.
In order to more accurately identify the anatomical sites of obstruction during sleep, sleep doping suggested as a preferred method. In a study of 127 patients, 63% had imbalances at one level while only 37% had multiple disease. However, the study may have wrongly identified the obstruction. heavy base obstruction that pushes the back of the back and causes secondary palatal obstruction may have been classified as primary palatal obstruction. Another study confirmed the high incidence of multilevel disease and 87% of their 893 patient populations had multiple levels of obstruction.
Since the majority of snores suffering from obstructive sleep apnea hypopneas syndrome have multilevel disease and control of therapy to a single anatomic level have great potential for failure, the need for multilevel therapy is evident. Historically, surgical treatment of obstructive sleep apnea hypopneas syndrome was often based on trials and errors. Snores would inadvertently undergo Uvulopalatopharyngoplasty (UPPP) as a first step. If the disease was not eliminated, they would continue to have hypopharyngeal surgery. However, planned multi-level operation in a single phase has become standard in many centers.
Many otolaryngologists assume that although Uvulopalatopharyngoplasty (UPPP) can not cure patients with severe OSAHS, it is likely that it is effective for patients with mild disease. However, there are many studies that indicate that the disease rate is not a predictor of single-use success. These patients underwent Uvulopalatopharyngoplasty (UPPP) and the success rate was only 40%.
The ideal procedure for OSAHS snores would have low morbidity, allow reasonable success, have little chance of changing the original upper aerodynamic function, and can be performed in a single step. In our experience, patients with severe illness and revealing sleepiness daily often have strong motivation for multilevel surgery with invasive procedures to handle the blocked sites. However, patients with mild or moderate obstructive sleep apnea are less prone to being willing to undergo aggressive surgical procedures.
Continuous positive airway pressure (CPAP) remains the first treatment for obstructive sleep apnea hypopneas syndrome. However, there is a significant percentage of obstructive patients with sleep apnea hypopneas syndrome which either fail or are unwilling to conduct continuous positive airway pressure (CPAP) treatment. For these patients, surgery provides a viable alternative chance of controlling obstructive sleep apnea hypopneas syndrome. The subjective and objective severity of obstructive sleep apnea hypopneas syndrome integrated with the degree of anatomical abnormality dictates the choice of surgical procedures. These range from simple to multilevel therapy with either minimally invasive or classically invasive technology in different combinations.
Snoring can be very frustrating problems, many people go through life without correction. The result is worrying relationships, years of sleepy nights and often health problems. Among those who have sleep apnea, most people love their CPAP machines and trust it. This then causes a problem for some because people never end up changing lifestyle until another health problem strikes.